The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Polymeric Lipid Hybrid Nanoparticles (PLNs) as Emerging Drug Delivery Platform—A Comprehensive Review of Their Properties, Preparation Methods, and Therapeutic Applications
Open accessAbstract
Polymeric lipid hybrid nanoparticles (PLNs) are core–shell nanoparticles made up of a polymeric kernel and lipid/lipid–PEG shells that have the physical stability and biocompatibility of both polymeric nanoparticles and liposomes. PLNs have emerged as a highly potent and promising nanocarrier for a variety of biomedical uses, including drug delivery and biomedical imaging, owing to recent developments in nanomedicine. In contrast with other forms of drug delivery systems, PLNs have been regarded as seamless and stable because they are simple to prepare and exhibit excellent stability. Natural, semi-synthetic, and synthetic polymers have been used to make these nanocarriers. Due to their small scale, PLNs can be used in a number of applications, including anticancer therapy, gene delivery, vaccine delivery, and bioimaging. These nanoparticles are also self-assembled in a reproducible and predictable manner using a single or two-step nanoprecipitation process, making them significantly scalable. All of these positive attributes therefore make PLNs an attractive nanocarrier to study. This review delves into the fundamentals and applications of PLNs as well as their formulation parameters, several drug delivery strategies, and recent advancements in clinical trials, giving a comprehensive insight into the pharmacokinetic and biopharmaceutical aspects of these hybrid nanoparticles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · cited 1×
“The Food and Drug Administration (FDA) licensed Doxil and Myocet, two of the popular doxorubicin liposomes, in 1995 and 1999, respectively, thereby paving the way for many others [19].”
BackgroundFactors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
Albanese, A., Tang, P. S., & Chan, W. C. W. (2012) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150124 · Cited by 3,633
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
Zhang, X.-F., Liu, Z.-G., Shen, W., & Gurunathan, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091534 · Cited by 3,220
Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
Abraham, J. (2010) · Handbook of Transnational Economic Governance Regimes · doi:10.1163/ej.9789004163300.i-1081.897 · Cited by 2,582
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433
(1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.10.1329 · Cited by 2,192
Liposomal Formulations in Clinical Use: An Updated Review
Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9020012 · Cited by 2,156
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
Investigation into the antibacterial behaviour of suspensions of ZnO nanoparticles (ZnO nanofluids)
Zhang, L., Jiang, Y., Ding, Y., Povey, M., & York, D. (2007) · Journal of Nanoparticle Research · doi:10.1007/s11051-006-9150-1 · Cited by 1,490
Moghimi, S. M., & Szebeni, J. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00033-x · Cited by 1,227
Li, X.-Q., Elliott, D. W., & Zhang, W.-X. (2006) · Critical Reviews in Solid State and Materials Sciences · doi:10.1080/10408430601057611 · Cited by 1,058
Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform
Zhang, L., Chan, J. M., Gu, F. X., Rhee, J.-W., Wang, A. Z., Radovic-Moreno, A. F., Alexis, F., Langer, R., & Farokhzad, O. C. (2008) · ACS Nano · doi:10.1021/nn800275r · Cited by 1,038
Govender, T. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00116-3 · Cited by 1,008
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
Sengupta, S., Eavarone, D., Capila, I., Zhao, G., Watson, N., Kiziltepe, T., & Sasisekharan, R. (2005) · Nature · doi:10.1038/nature03794 · Cited by 945
Trends and Developments in Liposome Drug Delivery Systems
Lian, T., & Ho, R. J. Y. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1023 · Cited by 907
Muller, R. H., & Keck, C. M. (2004) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2004.06.007 · Cited by 819
Nanomedicine: Developing smarter therapeutic and diagnostic modalities☆
FAROKHZAD, O., & LANGER, R. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.011 · Cited by 800
Enzyme-responsive polymeric assemblies, nanoparticles and hydrogels
Hu, J., Zhang, G., & Liu, S. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35103j · Cited by 722
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers
Gu, F., Zhang, L., Teply, B. A., Mann, N., Wang, A., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711714105 · Cited by 715
Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review
Hadinoto, K., Sundaresan, A., & Cheow, W. S. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.07.002 · Cited by 702
PLGA–lecithin–PEG core–shell nanoparticles for controlled drug delivery
Chan, J. M., Zhang, L., Yuet, K. P., Liao, G., Rhee, J.-W., Langer, R., & Farokhzad, O. C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.013 · Cited by 702
Polymeric nanoparticles: A study on the preparation variables and characterization methods
Crucho, C. I. C., & Barros, M. T. (2017) · Materials Science and Engineering: C · doi:10.1016/j.msec.2017.06.004 · Cited by 696
Freitas, C., & Müller, R. H. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00092-1 · Cited by 687
Enzyme-responsive nanomaterials for controlled drug delivery
Hu, Q., Katti, P. S., & Gu, Z. (2014) · Nanoscale · doi:10.1039/c4nr04249b · Cited by 668
Perrault, S. D., & Chan, W. C. W. (2009) · Journal of the American Chemical Society · doi:10.1021/ja907069u · Cited by 658
Genotoxicity of silver nanoparticles in Allium cepa
Kumari, M., Mukherjee, A., & Chandrasekaran, N. (2009) · Science of The Total Environment · doi:10.1016/j.scitotenv.2009.06.024 · Cited by 606
Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier
Lockman, P. R., Mumper, R. J., Khan, M. A., & Allen, D. D. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120001481 · Cited by 592 · cited 1×
“Apart from the existing advantages, polymeric NPs demonstrate the distinct drawbacks of toxic decay and toxic monomer accumulation, as well as a toxic degradation mechanism that hinders their utility [26].”
BackgroundChemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles☆
WONG, H., BENDAYAN, R., RAUTH, A., LI, Y., & WU, X. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.008 · Cited by 578
Nanoparticle-assisted Combination Therapies for Effective Cancer Treatment
Hu, C.-M. J., Aryal, S., & Zhang, L. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.13 · Cited by 564
Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA–PEG block copolymer
Yoo, H. S., & Park, T. G. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00340-0 · Cited by 538
Mukherjee, A., Waters, A. K., Kalyan, P., Achrol, A. S., Kesari, S., & Yenugonda, V. M. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s198353 · Cited by 493
Dong, Y., & Feng, S.-S. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.09.055 · Cited by 468
Core–shell-type lipid–polymer hybrid nanoparticles as a drug delivery platform
Mandal, B., Bhattacharjee, H., Mittal, N., Sah, H., Balabathula, P., Thoma, L. A., & Wood, G. C. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2012.11.010 · Cited by 467
Cancer theranostics: the rise of targeted magnetic nanoparticles
Cole, A. J., Yang, V. C., & David, A. E. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.03.001 · Cited by 425
Regulatory aspects on nanomedicines
Sainz, V., Conniot, J., Matos, A. I., Peres, C., Zupanǒiǒ, E., Moura, L., Silva, L. C., Florindo, H. F., & Gaspar, R. S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.023 · Cited by 417
Garcês, A., Amaral, M. H., Sousa Lobo, J. M., & Silva, A. C. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.11.023 · Cited by 396
Quality by Design: Concepts for ANDAs
Lionberger, R. A., Lee, S. L., Lee, L., Raw, A., & Yu, L. X. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9026-7 · Cited by 391
Manjunath, K., & Venkateswarlu, V. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.006 · Cited by 380
Singh, B., Kumar, R., & Ahuja, N. (2005) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v22.i1.20 · Cited by 352
Liu, Y., Li, K., Pan, J., Liu, B., & Feng, S.-S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.036 · Cited by 342
Silk fibroin nanoparticles for cellular uptake and control release
Kundu, J., Chung, Y.-I., Kim, Y. H., Tae, G., & Kundu, S. C. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.12.052 · Cited by 336
Valencia, P. M., Basto, P. A., Zhang, L., Rhee, M., Langer, R., Farokhzad, O. C., & Karnik, R. (2010) · ACS Nano · doi:10.1021/nn901433u · Cited by 335
Kora, A. J., Sashidhar, R. B., & Arunachalam, J. (2010) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2010.05.034 · Cited by 328
Lee, S. Y., Kim, H. J., Patel, R., Im, S. J., Kim, J. H., & Min, B. R. (2007) · Polymers for Advanced Technologies · doi:10.1002/pat.918 · Cited by 326
Wong, H. L., Rauth, A. M., Bendayan, R., Manias, J. L., Ramaswamy, M., Liu, Z., Erhan, S. Z., & Wu, X. Y. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0282-x · Cited by 303
Petersen, G. H., Alzghari, S. K., Chee, W., Sankari, S. S., & La-Beck, N. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.04.028 · Cited by 290
Cohen-Sela, E., Chorny, M., Koroukhov, N., Danenberg, H. D., & Golomb, G. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.073 · Cited by 285
A Review of the Structure, Preparation, and Application of NLCs, PNPs, and PLNs
Li, Q., Cai, T., Huang, Y., Xia, X., Cole, S., & Cai, Y. (2017) · Nanomaterials · doi:10.3390/nano7060122 · Cited by 282
Bagre, A. P., Jain, K., & Jain, N. K. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.08.037 · Cited by 266
Liposome circulation time and tumor targeting: implications for cancer chemotherapy
Gabizon, A. A. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00030-b · Cited by 255
Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration
Silva, M., Calado, R., Marto, J., Bettencourt, A., Almeida, A., & Gonçalves, L. (2017) · Marine Drugs · doi:10.3390/md15120370 · Cited by 255
Spatiotemporal controlled delivery of nanoparticles to injured vasculature
Chan, J. M., Zhang, L., Tong, R., Ghosh, D., Gao, W., Liao, G., Yuet, K. P., Gray, D., Rhee, J.-W., Cheng, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914585107 · Cited by 253
Salvador-Morales, C., Zhang, L., Langer, R., & Farokhzad, O. C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.005 · Cited by 250
Betancourt, T., Brown, B., & Brannon-Peppas, L. (2007) · Nanomedicine · doi:10.2217/17435889.2.2.219 · Cited by 249
Electrophoretic deposition of composite hydroxyapatite-chitosan coatings
Pang, X., & Zhitomirsky, I. (2007) · Materials Characterization · doi:10.1016/j.matchar.2006.05.011 · Cited by 225
Chen, S., & Sommers, J. M. (2001) · The Journal of Physical Chemistry B · doi:10.1021/jp011280n · Cited by 221
Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake
Vonarbourg, A., Passirani, C., Saulnier, P., Simard, P., Leroux, J. C., & Benoit, J. P. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30711 · Cited by 216
Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis
Costa, C., Moreira, J. N., Amaral, M. H., Sousa Lobo, J. M., & Silva, A. C. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.049 · Cited by 210
Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery.
Lasic, D. D., Čeh, B., Stuart, M. C. A., Guo, L., Frederik, P. M., & Barenholz, Y. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00159-z · Cited by 209
Steric Stabilization of Lipid/Polymer Particle Assemblies by Poly(ethylene glycol)-Lipids
Thevenot, J., Troutier, A.-L., David, L., Delair, T., & Ladavière, C. (2007) · Biomacromolecules · doi:10.1021/bm700753q · Cited by 198
Click Chemistry for Drug Delivery Nanosystems
Lallana, E., Sousa-Herves, A., Fernandez-Trillo, F., Riguera, R., & Fernandez-Megia, E. (2012) · Pharmaceutical Research · doi:10.1007/s11095-011-0568-5 · Cited by 193
Direct synthesis and structure characterization of ultrafine CeO2nanoparticles
Hu, C., Zhang, Z., Liu, H., Gao, P., & Wang, Z. L. (2006) · Nanotechnology · doi:10.1088/0957-4484/17/24/013 · Cited by 192
Richter, A. M., Waterfield, E., Jain, A. K., Canaan, A. J., Allison, B. A., & Levy, J. G. (1993) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1993.tb02962.x · Cited by 182
Design of Experiments: A Realistic Approach
Anderson, V. L., & McLean, R. A. (2018) · CRC Press eBooks · doi:10.1201/9781315141039 · Cited by 165
Drug Delivery Across the Blood-Brain Barrier
Chen, Y., Dalwadi, G., & Benson, H. (2004) · Current Drug Delivery · doi:10.2174/1567201043334542 · Cited by 162
Shi, Q., Vitchuli, N., Nowak, J., Caldwell, J. M., Breidt, F., Bourham, M., Zhang, X., & McCord, M. (2011) · European Polymer Journal · doi:10.1016/j.eurpolymj.2011.04.002 · Cited by 161
LIPID–POLYMER HYBRID NANOPARTICLES: SYNTHESIS, CHARACTERIZATION AND APPLICATIONS
Zhang, L., & Zhang, L. (2010) · Nano LIFE · doi:10.1142/s179398441000016x · Cited by 156
Cunha, S., Costa, C. P., Moreira, J. N., Lobo, J. M. S., & Silva, A. C. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102206 · Cited by 136
Quality-by-design of nanopharmaceuticals – a state of the art
Bastogne, T. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.05.014 · Cited by 134
Quality-by-design approach as a systematic tool for the development of nanopharmaceutical products
Beg, S., Rahman, M., & Kohli, K. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.12.002 · Cited by 133
Chime, S. A. (2013) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajppx2013.0004 · Cited by 128
Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery
Hallan, S. S., Kaur, P., Kaur, V., Mishra, N., & Vaidya, B. (2014) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2014.951721 · Cited by 117
Kaur, A., Jain, S. K., & Tiwary, A. K. (2008) · Acta Pharmaceutica · doi:10.2478/v10007-007-0045-1 · Cited by 116
Zielińska, A., Ferreira, N. R., Feliczak‐Guzik, A., Nowak, I., & Souto, E. B. (2020) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2020.1744008 · Cited by 104
Manjunath, K., & Venkateswarlu, V. (2006) · Journal of drug targeting · doi:10.1080/10611860600888850 · Cited by 103
Attama, A. A., & Nkemnele, M. O. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.08.018 · Cited by 100
Lin, C.-I., Joseph, A. K., Chang, C. K., & Lee, Y. D. (2004) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2003.10.017 · Cited by 96
Strategies for optimizing polymer-lipid hybrid nanoparticle-mediated drug delivery
Wu, X. Y. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1165662 · Cited by 95
Soni, G., Kale, K., Shetty, S. R., Gupta, M., & Yadav, K. S. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03846 · Cited by 92
Patil, G. B., Patil, N. D., Deshmukh, P. K., Patil, P. O., & Bari, S. B. (2014) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2014.909820 · Cited by 75
Xie, L., Beyer, S., Vogel, V., Wacker, M. G., & Mäntele, W. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.03.080 · Cited by 60
Vandorpe, J., Schacht, E. H., Dunn, S. E., Hawley, A. E., Stolnik, S., Davis, S. S., Garnett, M. C., Davies, M. C., & Illum, L. (1997) · Biomaterials · doi:10.1016/s0142-9612(97)00052-5 · Cited by 58
Effect of additives on the release of a model protein from PLGA microspheres
Kang, F., & Singh, J. (2001) · AAPS PharmSciTech · doi:10.1007/bf02830570 · Cited by 58
Extended‐Release Epidural Morphine (DepoDur™): An Old Drug with a New Profile
Alam, M., & Hartrick, C. T. (2005) · Pain Practice · doi:10.1111/j.1533-2500.2005.00048.x · Cited by 52
Kim, D., & Chien, Y. W. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950141c · Cited by 50
Polymeric Lipid Hybrid Nanoparticles: Properties and Therapeutic Applications
Jose, C., Amra, K., Bhavsar, C., Momin, M. M., & Omri, A. (2018) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2018024751 · Cited by 49
Gao, J., Lü, C., Lü, X., & Du, Y. (2007) · Journal of Materials Chemistry · doi:10.1039/b709566j · Cited by 33
Sehouli, J., Stengel, D., Oskay, G., Camara, O., Hindenburg, H.-J., Klare, P., Blohmer, J., Heinrich, G., Elling, D., Ledwon, P., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf294 · Cited by 32
Arnold, Y. E., González, R. C. B., Versace, H., & Kuentz, M. (2010) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(10)50019-4 · Cited by 13
Cited by
Advances in drug delivery systems, challenges and future directions
Ezike, T. C., Okpala, U. S., Onoja, U. L., Nwike, C. P., Ezeako, E. C., Okpara, O. J., Okoroafor, C. C., Eze, S. C., Kalu, O. L., Odoh, E. C., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17488 · Cited by 1,040
Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases
Onugwu, A. L., Nwagwu, C. S., Onugwu, O. S., Echezona, A. C., Agbo, C. P., Ihim, S. A., Emeh, P., Nnamani, P. O., Attama, A. A., & Khutoryanskiy, V. V. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.018 · Cited by 350
Kim, M., Shin, M., Zhao, Y., Ghosh, M., & Son, Y. (2024) · Small Science · doi:10.1002/smsc.202400280 · Cited by 97
Exosome-mediated delivery of siRNA molecules in cancer therapy: triumphs and challenges
Ubanako, P., Mirza, S., Ruff, P., & Penny, C. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1447953 · Cited by 68
PLGA-Based Co-Delivery Nanoformulations: Overview, Strategies, and Recent Advances
Stevanović, M. M., Qian, K., Huang, L., & Vukomanović, M. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17121613 · Cited by 42
Metadata
- Authors
- Sivadasan, D., Sultan, M. H., Madkhali, O., Almoshari, Y., & Thangavel, N.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2021-08-18
- Volume
- 13
- Issue
- 8
- Pages
- 1291
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W3193314416
- Cited by
- 288
- References
- 95
- FWCI
- 5.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.